[Risk of Multiple Sclerosis: Analysis of Interactions Between Variants of Nuclear and Mitochondrial Genomes]. 2021

M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
Pirogov Russian National Research Medical University, Moscow, 117997 Russia.

There is increasing evidence that the interaction of the mitochondrial and nuclear genomes substantially affects the risk of neurodegenerative diseases. The role of mitonuclear interactions in the development of multiple sclerosis, a severe chronic neurodegenerative disease of a polygenic nature, is poorly understood. In this work, we analyzed the association of multiple sclerosis with two-component mitonuclear combinations that include each of seven polymorphic variants of the nuclear genome localized in the region of the UCP2, and KIF1B genes and in the PVT1 locus (MYC, PVT1, and MIR1208 genes) and each often polymorphisms of the mitochondrial genome, as well as individual genetic variants that make up these combinations. Association of the individual components of these combinations with multiple sclerosis was also evaluated. 507 patients with multiple sclerosis and 321 healthy individuals were enrolled in the study, all participants were ethnic Russians. Two mitonuclear combinations associated with multiple sclerosis were identified: the UCP2 (rs660339)*A + MT-ATP6 (rs193303045)*G combination was characterized by p-value = 0.015 and OR= 1.39 [95% CI 1.05-1.87], and the PVT1 (rs2114358)*G + MT-ND1 (rs1599988)*ะก combination - by p-value = 0.012 and OR = 1.77 [95% CI 1.10-2.84]. Only one of the individual components of these combinations, allele rs660339*A of the nuclear gene UCP2 encoding uncoupling protein 2 of the mitochondrial anion carrier family, was independently associated with multiple sclerosis (p = 0.028; OR = 1.36 [95% CI 1.01-1.84]). This study expands the current understanding of the role of mitonuclear interactions and variance of nuclear genes, whose products function in mitochondria, and in risk of MS.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D004272 DNA, Mitochondrial Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins. Mitochondrial DNA,mtDNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D054629 Genome, Mitochondrial The genetic complement of MITOCHONDRIA as represented in their DNA. Mitochondrial Genome,Genomes, Mitochondrial,Mitochondrial Genomes
D019636 Neurodegenerative Diseases Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures. Degenerative Diseases, Nervous System,Degenerative Diseases, Central Nervous System,Degenerative Diseases, Neurologic,Degenerative Diseases, Spinal Cord,Degenerative Neurologic Diseases,Degenerative Neurologic Disorders,Nervous System Degenerative Diseases,Neurodegenerative Disorders,Neurologic Degenerative Conditions,Neurologic Degenerative Diseases,Neurologic Diseases, Degenerative,Degenerative Condition, Neurologic,Degenerative Conditions, Neurologic,Degenerative Neurologic Disease,Degenerative Neurologic Disorder,Neurodegenerative Disease,Neurodegenerative Disorder,Neurologic Degenerative Condition,Neurologic Degenerative Disease,Neurologic Disease, Degenerative,Neurologic Disorder, Degenerative,Neurologic Disorders, Degenerative
D020641 Polymorphism, Single Nucleotide A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. SNPs,Single Nucleotide Polymorphism,Nucleotide Polymorphism, Single,Nucleotide Polymorphisms, Single,Polymorphisms, Single Nucleotide,Single Nucleotide Polymorphisms

Related Publications

M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
January 1980, Molecular & general genetics : MGG,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
January 1996, Annual review of biochemistry,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
March 2022, Mitochondrion,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
May 2018, Scientific reports,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
January 2009, Advances in experimental medicine and biology,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
April 2020, Scientific reports,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
December 2022, International journal of molecular sciences,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
January 2017, Nature reviews. Neurology,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
July 2019, Immunological investigations,
M S Kozin, and I S Kiselev, and N M Baulina, and G V Pavlova, and A N Boyko, and O G Kulakova, and O O Favorova
May 2019, Neuroscience letters,
Copied contents to your clipboard!